Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Monogram Orthopaedics (NASDAQ:MGRM) Head-To-Head Survey

Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings.

Valuation and Earnings

This table compares Inspira Technologies Oxy B.H.N. and Monogram Orthopaedics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies Oxy B.H.N.	N/A	N/A	-$11.29 million	N/A	N/A
Monogram Orthopaedics	$370,000.00	238.32	-$13.74 million	($0.47)	-5.47

Inspira Technologies Oxy B.H.N. has higher earnings, but lower revenue than Monogram Orthopaedics.

Institutional & Insider Ownership

12.7% of Inspira Technologies Oxy B.H.N. shares are held by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are held by institutional investors. 29.4% of Inspira Technologies Oxy B.H.N. shares are held by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Inspira Technologies Oxy B.H.N. and Monogram Orthopaedics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies Oxy B.H.N.	0	0	0	0	0.00
Monogram Orthopaedics	0	0	1	1	3.50

Monogram Orthopaedics has a consensus price target of $4.00, suggesting a potential upside of 55.64%. Given Monogram Orthopaedics’ stronger consensus rating and higher probable upside, analysts clearly believe Monogram Orthopaedics is more favorable than Inspira Technologies Oxy B.H.N..

Risk and Volatility

Inspira Technologies Oxy B.H.N. has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.

Profitability

This table compares Inspira Technologies Oxy B.H.N. and Monogram Orthopaedics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspira Technologies Oxy B.H.N.	N/A	N/A	N/A
Monogram Orthopaedics	N/A	-130.90%	-106.38%

Summary

Inspira Technologies Oxy B.H.N. beats Monogram Orthopaedics on 6 of the 11 factors compared between the two stocks.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.